InflaRx (IFRX) Cash & Equivalents (2022 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

InflaRx's Cash & Equivalents history spans 2 years, with the latest figure at $19.6 million for Q4 2024.

• For Q4 2024, Cash & Equivalents changed N/A year-over-year to $19.6 million; the TTM value through Dec 2024 reached $19.6 million, changed N/A, while the annual FY2024 figure was $19.9 million, N/A changed from the prior year.
• Cash & Equivalents for Q4 2024 was $19.6 million at InflaRx, up from $16.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $19.6 million in Q4 2024 and bottomed at $16.6 million in Q4 2022.

Peer Comparison